Lasamide, a Potent Human Carbonic Anhydrase Inhibitor from the Market: Inhibition Profiling and Crystallographic Studies
Lasamide is a synthetic precursor and a contaminant of the diuretic Furosemide manufacturing process and represents a highly valuable building block for fragment-based drug discovery approaches. We assessed the ability of Lasamide to inhibit in vitro the human-expressed Carbonic Anhydrases by means of the stopped-flow technique, and we assessed its binding modes within hCAs II and XII-mimic catalytic clefts by X-ray crystallography. Interestingly, an unprecedented crystal form for the hCA IX mimic H-tag is reported and discussed herein.
Authors
- Clemente Capasso (ORCID: https://orcid.org/0000-0003-0763-4439)
- Yasinalli Tamboli (ORCID: https://orcid.org/0000-0002-5161-0170)
- Jaydeo T. Kilbile (ORCID: https://orcid.org/0000-0003-3716-4677)
- Marta Ferraroni (ORCID: https://orcid.org/0000-0001-7258-738X)
- Claudiu T. Supuran (ORCID: https://orcid.org/0000-0003-4262-0323)
- Simone Carradori (ORCID: https://orcid.org/0000-0002-8698-9440)
- Fabrizio Carta (ORCID: https://orcid.org/0000-0002-1141-6146)
- Ilaria D’Agostino (ORCID: https://orcid.org/0000-0002-4870-7326)
- Gioele Renzi (ORCID: https://orcid.org/0009-0008-9109-030X)
- Chiara Baroni (ORCID: https://orcid.org/0009-0002-1401-1205)
Institutions
- University of Pisa (IT)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- University of Chieti-Pescara (IT)
- King Abdullah International Medical Research Center (SA)
- Institute of Biosciences and Bioresources (IT)
- National Research Council (IT)
- University of Florence (IT)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1021/acsmedchemlett.4c00341
- Citations
- 8
- Primary Topic
- Enzyme function and inhibition
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- Università degli Studi di Firenze
- Università degli Studi G. d'Annunzio Chieti - Pescara
- Università di Pisa
- King Abdullah International Medical Research Center